Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 23630159

Pilot study of vincristine, oral irinotecan, and temozolomide (VOIT regimen) combined with bevacizumab in pediatric patients with recurrent solid tumors or brain tumors.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Pediatr Blood Cancer
Publication date
2013 Sep
First author
Wagner L

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships

    Authors and identifiers

    1. name
      Wagner L
      type
      Author
    2. name
      Turpin B
      type
      Author
    3. name
      Nagarajan R
      type
      Author
    4. name
      Weiss B
      type
      Author
    5. name
      Cripe T
      type
      Author
    6. name
      Geller J
      type
      Author
    Complete bibliographic record and source provenance
    authors
    1. name
      Wagner L
      type
      Author
    2. name
      Turpin B
      type
      Author
    3. name
      Nagarajan R
      type
      Author
    4. name
      Weiss B
      type
      Author
    5. name
      Cripe T
      type
      Author
    6. name
      Geller J
      type
      Author
    bibliography ids
    1. nci-bib-1e15e3b7d310492c32d56345
    book metadata
    content sha256
    70ce730891d0314f782fdf82d9060026204b3e41dc7216650270e95b0a70b98f
    document type
    citation
    dois
    1. 10.1002/pbc.24547
    electronic publication date
    display
    2013 Apr 29
    precision
    day
    year
    2013
    evidence scope
    bibliographic_metadata_only
    id
    pubmed:23630159
    immutable id
    pubmed:23630159@70ce730891d0314f782fdf82d9060026204b3e41dc7216650270e95b0a70b98f
    journal
    abbreviation
    Pediatr Blood Cancer
    issn electronic
    1545-5017
    issn print
    1545-5009
    issue
    9
    name
    Pediatric blood & cancer
    nlm unique id
    101186624
    pages
    1447-51
    volume
    60
    languages
    1. eng
    notices
    absence is not clearance
    true
    has correction metadata
    false
    has expression of concern metadata
    false
    has retraction in link
    false
    pubmed marks article retracted
    false
    pubmed marks retraction notice
    false
    relationships
      outcomes validated
      false
      pmid
      23630159
      provenance
      batch id
      99e008dabc339d38fd44
      provider
      NCBI PubMed ESummary
      record sha256
      7597fd8fcfe7a5da1d17d5f617745ab84ec9805a7fb2a383f783580d18e6c1b0
      response sha256
      804916232567480946eda9a00aff276bc44fd9a6d15d9336e773a9c803123d39
      retrieved at
      2026-09-09T23:46:55.094762+00:00
      publication date
      display
      2013 Sep
      precision
      month
      year
      2013
      publication types
      1. Clinical Trial
      2. Journal Article
      record status
      PubMed - indexed for MEDLINE
      schema version
      1.0
      source url
      https://pubmed.ncbi.nlm.nih.gov/23630159/
      title
      Pilot study of vincristine, oral irinotecan, and temozolomide (VOIT regimen) combined with bevacizumab in pediatric patients with recurrent solid tumors or brain tumors.

      Preserved source evidence · Not medical advice